|
|
||||||||
Ann Thorac Surg 1994;58:216-221
© 1994 The Society of Thoracic Surgeons
a Section of Cardiothoracic Anesthesia, Department of Anesthesia The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina USA
b Department of Cardiothoracic Surgery The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina USA
c Section of Hematology and Oncology, Department of Medicine The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina USA
d Department of Biostatistics, The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina USA
Accepted for publication November 30, 1993.
* Address reprint requests to Dr Gravlee. Department of Anesthesiology, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212.
This study ptospectively evaluated numerous tests of clolting function in 897 consecutive adult cardiac surgical patients over 18 months. This included coronary operation, valve replacement, and reoperative patients. The tests included activated clotting time, activated partial thromboplastin time, prothrombin time, thiombin time, fibrinogen, fibrin/fibrinogen degradation products, platelet count, and Duke's earlobe bleeding time. Other variables such as age, sex, and cardiopulmonary bypass duration were included in the multivariate analysis. Statistically significant correlations were found between 16-hour mediastinal drainage and activated partial thromboplastin time, fibrinogen, activated clotting time, fibrin/fibrinogen degradation products, platelet count, and prothrombin time. Scatter plots indicate that these relationships, although statistically significant, had little predictive value and were largely significant is a result of the large number of patients in each group, which permitted weak correlations to reach statistical significance. The best multivariate model constructed could explain only 12% of the observed variation in postoperative blood loss. Because the predictive values of the tests are so low, it does not appear sensible to screen patients routinely using these clotting tests shortly after cardiopulmonary bypass.
This article has been cited by other articles:
![]() |
M. A. Mont, J. J. Jacobs, L. N. Boggio, K. J. Bozic, C. J. Della Valle, S. B. Goodman, C. G. Lewis, A. J. Yates Jr, W. C. Watters III, C. M. Turkelson, et al. Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty J. Am. Acad. Orthop. Surg., December 1, 2011; 19(12): 768 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sucker, K. Tharra, J. Litmathe, R. Scharf, and R. Zotz Rotation thromboelastography (ROTEM) parameters are influenced by age, gender, and oral contraception Perfusion, July 1, 2011; 26(4): 334 - 340. [Abstract] [PDF] |
||||
![]() |
A. Shander and D. Moskowitz Hydroxyethyl starch and risk of bleeding: the missing links. Anesth. Analg., March 1, 2006; 102(3): 968 - 968. [Full Text] [PDF] |
||||
![]() |
R. Poston, J. Gu, J. Manchio, A. Lee, J. Brown, J. Gammie, C. White, and B. P. Griffith Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting Eur J Cardiothorac Surg, April 1, 2005; 27(4): 584 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S Hall and A. J Skoultchi Transfusion for Coagulopathy After Heart Surgery: Efficacy of Laboratory Studies Asian Cardiovasc Thorac Ann, March 1, 2002; 10(1): 16 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Despotis and L. T. Goodnough Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery Ann. Thorac. Surg., August 1, 2000; 70(2): S20 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Despotis, J. H. Joist, and L. T. Goodnough Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes Clin. Chem., September 1, 1997; 43(9): 1684 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H Stammers, L. W Fristoe, K. Christensen, J. Deptula, R T. Sydzyik, D. Zavadil, and L. Willett Coagulopathic-induced membrane dysfunction during extracorporeal membrane oxygenation: a case report Perfusion, March 1, 1997; 12(2): 143 - 149. [Abstract] [PDF] |
||||
![]() |
D. J. Kuter Thrombopoietin: Biology and Clinical Applications Oncologist, February 1, 1996; 1(1): 98 - 106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |